School of Medicine
Showing 911-920 of 1,300 Results
-
Ethan Solomon
Instructor, Psychiatry and Behavioral Sciences
BioDr. Solomon is an Instructor in the Department and Psychiatry and Behavioral Sciences and a member of the Stanford Precision Neurotherapeutics Lab. He earned his MD and PhD in Bioengineering through the Medical Scientist Training Program at the University of Pennsylvania, and completed residency training in psychiatry at the Stanford School of Medicine. His research focuses on electrophysiological techniques (stereo-EEG/ECoG, scalp EEG) and brain stimulation technologies (direct electrical stimulation, deep brain stimulation, and transcranial magnetic stimulation) to understand cognitive and perceptual processes in psychiatric illness. Dr. Solomon is a recipient of an NIMH K99 grant to study the use of theta burst stimulation in hippocampal-cortical networks of patients with schizophrenia.
-
Natalie Solomon
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Solomon is a licensed psychologist, board certified in behavioral sleep medicine, and a clinical associate professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Dr. Solomon conducts research as a member of the Computational Psychiatry, Neuroimaging, Sleep Lab (CoPsyN Sleep Lab) and treats patients in the Sleep Health and Insomnia Program (SHIP). Dr. Solomon specializes in the study and treatment of sleep disorders. Her clinical interests include the intersection of sleep difficulties with overall quality of life and women’s health. Dr. Solomon enjoys treating a variety of sleep difficulties, including insomnia, hypnotic dependence, circadian rhythm disturbances, NREM parasomnias, and nightmares. Dr. Solomon additionally consults, teaches undergrads, graduate students, and continuing studies, supervises postdoctoral fellows, and trains providers to deliver insomnia treatment.
-
David Solow-Cordero
Associate Director, High-Throughput Screening, Innovative Medicines Accelerator (IMA)
Current Role at StanfordAssociate Director, High-Throughput Screening Knowledge Center, , Sarafan ChEM-H and Innovative Medicine Accelerator (IMA)
This high-throughput screening (HTS) laboratory allows Stanford researchers and others to discover novel modulators of targets that otherwise would not be practical in industry. The center incorporates instrumentation (purchased with NCRR NIH Instrumentation grant numbers S10RR019513, S10RR026338, S10OD025004, and S10OD026899), databases, compound libraries, and personnel whose previous sole domains were in industry.
Among our instrumentation are a fully automated Molecular Devices ImageXpress Micro Confocal High-Content fluorescence microplate imager, with live cell, fluidics and phase contrast options, an Echo 655 Acoustic Dispense, a Thermo integrated HTS robotic system, a Caliper Life Sciences SciClone ALH3000 and an Agilent Bravo microplate liquid handler, and the BMG Clariostarplus, Tecan Infinite M1000 and M1000 PRO and Molecular Devices FlexStation II 384 fluorescence, luminescence and absorbance multimode microplate readers.
We have over 180,000 small molecules for compound screens, 15,000 cDNAs for genomic screens, and whole genome siRNA libraries targeting the human genome (the siARRAY whole human genome siRNA library from Dharmacon, targeting 21,000 human genes) and the mouse genome (Qiagen mouse whole genome siRNA set V1 against 22,124 genes).
The HTSKC main screening lab is located in ChEM-H W008, the cell-based assay development lab is located in CCSR Room 0133-North Wing, between the Transgenic Mouse Facility, and the Stanford Genomics Facility. -
Shamsi Soltani
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2021
BioShamsi Soltani is a PhD candidate in the Department of Epidemiology and Population Health and a trainee with the Center for Population Health Sciences, both in the Stanford School of Medicine. For three years, she was a fellow in the NIH T-32 Training in Advanced Data Analytics for Behavioral and Social Sciences (TADA-BSSR) program, supervised by Drs. Abby King and Lorene Nelson. Her dissertation work revolves around modifiable risk factors for suicide in LGBTQ+ populations and is mentored by Dr. Mitchell Lunn.
